Laboratory assessment

Urologia Internationalis

Volumn 79, Issue SUPPL. 1, 2007, Pages 20-25

  Prezioso, Domenico ^a   Di Martino, Mario ^a   Galasso, Raffaele ^a   Iapicca, Gennaro ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Basic laboratory evaluation; Blood specific tests; Urine specific tests

Indexed keywords

ACETAZOLAMIDE; ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CALCIUM; CHLORIDE; CITRIC ACID; COLECALCIFEROL; CREATININE; CYCLIC AMP; ELECTROLYTE; GLUCOSE; INDINAVIR; LIOTHYRONINE; MAGNESIUM; OXALIC ACID; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; SODIUM; SULFONAMIDE; THYROTROPIN; THYROXINE; TRIAMTERENE; URATE; UREA; URIC ACID; VITAMIN D;

ARTICLE; CROHN DISEASE; CYSTINURIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCALCIURIA; HYPERTHYROIDISM; HYPERURICOSURIA; HYPOMAGNESEMIA; INFECTION; INTESTINE RESECTION; KIDNEY TUBULE ACIDOSIS; LABORATORY TEST; LEUKOCYTE COUNT; MALABSORPTION; NEPHROLITHIASIS; OXALOSIS 1; PH MEASUREMENT; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; SARCOIDOSIS; URINALYSIS;

BLOOD CHEMICAL ANALYSIS; HUMANS; NEPHROLITHIASIS; RISK ASSESSMENT; RISK FACTORS; URINALYSIS;

EID: 34548219423     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104437     Document Type: Article

References (25)

1. Roger L, Glenn M: Medical treatment: worthwhile and when? EAU Update Ser 2005;3:10-16.
2. Clark JY, Thompson IM, Optenburg SA: Economical impact of urolithiasis in US. J Urol 1995;154:2020-2024.
3. Tiselius HG: Epidemiology and medical management of stone disease. BJU Int 2003;91:758-767.
4. Ibrahim AIA, Shelty SE, Award RM, Patel KP: Prognostic factors in the conservative treatment of ureteric stones. Br J Urol 1991;67:358-361.
5. Pak CYC: Kidney stones. Lancet 1998;351:1797-1801.
6. Hess B, Hasler-Strub U, Ackermann D, Jaeger PH: Metabolic evaluation of patients with recurrent idiopatic calcium nephrolithiasis. Nephrol Dial Transplant 1997;12:1362-1368.
7. Bek-Jensen H, Tiselius HG: Repeated urine analysis in patients with calcium stone disease. Eur Urol 1998;33:323-332.
8. Hobarth K, Hofbauer J, Szabo N: Value of repeated analysis of 24-hour urine in recurrent calcium urolithiasis. Urology 1994;44:20-25.
9. Tiselius HG: An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chem Acta 1982;122:409-418.
10. Tiselius HG: Metabolic evaluation of patients with urolithiasis. Urol Int 1997;59:131-141.
11. Bek-Jensen H, Tiselius HG: Evaluation of urine composition and calcium salt crystallization properties in standardized 12-h night urine from normal subjects and calcium stone formers. Urol Res 1997;25:365-372.
12. Pak CYC, Kaplan RA, Bone H, Townsend J, Waters O: A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975;292:497-500.
13. Pak CYC, Britton F, Peterson R: Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 1980;69:19-30.
14. Coe FL, Parks JH: Primary Hyperparathyroidism. Nephrolithiasis: Pathogenesis and Treatment, ed 2. Chicago, Year Book Medical, 1988, pp 59-107.
15. Coe FL, Favus MJ: Disorders of stone formations; in Brenner BM, Rector FC Jr (eds): The Kidney. Saunders, Philadelphia, 1986, p 1403.
16. Milliner DS: Cystinuria. Endocrinol Metab Clin North Am 1990;19:889-907.
17. Pak CYC, Skurla C, Harvey C: Graphic display of urinary risk factors for renal stone formation. J Urol 1985;134:867-860.
18. McLeod RS, Churchill DN: Urolithiasis complicating inflammatory bowel disease. J Urol 1992;148:974-978.
19. Moe OW, Bonny O: Genetic hypercalciuria. J Am Soc Nephrol 2005;16:729-745.
20. Gambaro G: Genetic of hypercalciuria and calcium nephrolithiasis. Am J Kidney Dis 2004;44:963-986.
21. Berg C, Larsson L, Tiselius HG: The composition of four-hour urine samples from patients with calcium oxalate stone disease. Br J Urol 1987;60:301-306.
22. Strohmaier WL, Hoelz K-J, Bichler KH: Spot urine samples for the metabolic evaluation of urolithiasis patients. Eur Urol 1997;32:294-300.
23. Tiselius HG: A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur Urol 1984;10:191-195.
24. Tiselius HG: Aspects on estimation of risk of calcium oxalate crystallization in urine. Urol Int 1991;47:255-259.
25. Tiselius HG: Risk formulas in calcium oxalate urolithiasis. World J Urol 1997;15:176-185.